XENLISTIQ

EUIPO EUIPO 2013 Application withdrawn

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark XENLISTIQ was filed as Word mark on 02/28/2013 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 011614931
Application date February 28, 2013
Publication date June 20, 2013

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Bedford House, John Street WC1N 2BF London GB

Objection / Complaint

09/20/2013: Likelihood of confusion
Trademark
Applicant
GlaxoSmithKline Intellectual Property Limited

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; pharmaceutical preparations; antidepressants

ID: 11011614931